Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

LinkDoc Technology IPO Valuation Analysis

LinkDoc (零氪科技) Pre-IPO - Intricately Embedded in the Oncology Industry

LinkDoc Technology IPO Initiation: Building with Big Data

We Doctor IPO Initiation: Patient Revolution

Equity Capital Markets

<div class="content-highlight">
<p style="text-align: left;">Founded in 2014, <a href="https://www.smartkarma.com/entities/linkdoc-technology-limited" target="_blank" data-smartkarma-citation="entities:33499:1" rel="noopener">LinkDoc (LDOC US)</a> is getting ready for an IPO in the United States in the coming days. <a href="https://www.reuters.com/technology/alibaba-health-backed-linkdoc-files-us-ipo-2021-06-14/" target="_blank" rel="noopener">LinkDoc Technology</a> is a medical data company in China backed by Alibaba Health Information Tech's subsidiary. Other major investors include Ally Bridge Group and CBC Capital.</p>
<p style="text-align: left;">LinkDoc provides oncology (cancer-focused) healthcare services. The company plans to use the IPO proceeds to strengthen R&amp;D, M&amp;As, and working capital. Morgan Stanley, BofA Securities and CICC are the main underwriters for the IPO.</p>
<p style="text-align: left;">LinkDoc is planning to raise about $500 million in this IPO. LinkDoc provides big data and AI driven healthcare services with focus on cancer-related cares. One of the company's leading competitor is <a href="https://www.smartkarma.com/entities/yidu-tech-inc" target="_blank" data-smartkarma-citation="entities:29245:1" rel="noopener">Yidu Tech Inc (2158 HK)</a> which raised $610 million in a Hong Kong IPO listing in January 2021.</p>
</div>


Founded in 2014, LinkDoc (LDOC US) is getting ready for an IPO in the United States in the coming days. LinkDoc Technology is a medical data company in China backed by Alibaba Health Information Tech's subsidiary. Other major investors include Ally Bridge Group and CBC Capital.
LinkDoc provides oncology (cancer-focused) healthcare services. The company plans to use the IPO proceeds to strengthen R&amp;D, M&amp;As, and working capital. Morgan Stanley, BofA Securities and CICC are the main underwriters for the IPO.
LinkDoc is planning to raise about $500 million in this IPO. LinkDoc provides big data and AI driven healthcare services with focus on cancer-related cares. One of the company's leading competitor is Yidu Tech Inc (2158 HK) which raised $610 million in a Hong Kong IPO listing in January 2021.


LinkDoc

LinkDoc Technology IPO Preview